Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
49,253,118
-
Share change
-
+5,829,576
-
Total reported value
-
$718,106,733
-
Price per share
-
$14.58
-
Number of holders
-
78
-
Value change
-
+$171,146,186
-
Number of buys
-
48
-
Number of sells
-
26
Institutional Holders of AMRYT PHARMA PLC - SPONSORED ADS (AMYT) as of Q1 2023
As of 31 Mar 2023,
AMRYT PHARMA PLC - SPONSORED ADS (AMYT) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,253,118 shares.
The largest 10 holders included
Athyrium Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Stonepine Capital Management, LLC, MPM ASSET MANAGEMENT LLC, MORGAN STANLEY, Pentwater Capital Management LP, UBS OCONNOR LLC, TIG Advisors, LLC, ALPINE ASSOCIATES MANAGEMENT INC., and Rock Springs Capital Management LP.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.